InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.84
(
0.00%
)
US TECH 100
17,728.40
(
0.26%
)
Dow Jones
39,527.49
(
0.04%
)
Brent Oil
83.11
(
0.87%
)
Bitcoin
62,762.34
(
2.14%
)
Post# of 290
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jockinmikeg

Send PM Follow Ignore
Followers 68
Posts 2644
Boards Moderated 0
Alias Born 08/20/2013

jockinmikeg

Re: None

Thursday, 01/30/2014 1:13:53 AM

Thursday, January 30, 2014 1:13:53 AM

Post# of 290
European Medicines Agency Accepts Marketing Authorization Application for Biovest’s Cancer Vaccine for Treatment of Non-Hodgkin’s Follicular Lymphoma

With the MAA acceptance, the KLH-based cancer vaccine, BiovaxID, has begun the review process by the European Medicines Agency (EMA) to secure approval to market BiovaxID in the EU and to allow prescription and sale of BiovaxID for the treatment of non-Hodgkin’s follicular lymphoma in patients who have achieved a first complete remission.

http://www.businesswire.com/news/home/20140113005588/en/European-Medicines-Agency-Accepts-Marketing-Authorization-Application#.Uunpd_mwJAr

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up